These nanomaterials are capable of selective attachment to the transferrin receptor (TfR) expressed on lung cancer cells, as well as accurately modulating drug release based on the pH levels and the quantity of reactive oxygen species. The gene discussed is TFRC; the disease is lung carcinoma.